Insider · CIK 0001120302
Joseph Bayern
director
Files at CGC (Canopy Growth Corp). First filing Apr 2, 2026, latest Sep 30, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $8,294 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGC: Canopy Growth Corp
CGCOct 9, 2026 · close 0.83
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Canopy Growth Corp | $2,869 3,096 shares | -2% | - | |
| 23Weak | Canopy Growth Corp | $2,953 3,197 shares | -2% | +10% from low-51% from high | |
| 23Weak | Canopy Growth Corp | $2,472 2,658 shares | -6% | +15% from low-51% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | CGC Canopy Growth Corp | SOpen-market sale Common Shares | -3,096 | $0.93 | $2,869 | 142,031 | 13 d ago |
| Jun 26, 2026 | CGC Canopy Growth Corp | SOpen-market sale Common Shares | -3,197 | $0.92 | $2,953 | 145,127 | Jun 29, 2026 |
| Jun 17, 2026 | CGC Canopy Growth Corp | AGrant or award Common Shares | +108,324 | $0.00 | $0 | 148,324 | Jun 22, 2026 |
| Mar 31, 2026 | CGC Canopy Growth Corp | SOpen-market sale Common Shares | -2,658 | $0.93 | $2,472 | 40,000 | Apr 2, 2026 |
| Nov 11, 2025 | CGC Canopy Growth Corp | AGrant or award Common Shares | +42,658 | $0.00 | $0 | 42,658 | Nov 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.